IDH1 and glioblastoma: Since the mutation of IDH1-R132H and MGMT in GBM patients is strongly associated with the OS and PFS, Bae integrated radiomics with clinical and genetic profiles and built several models to predict the prognosis of 217 GBM patients (training: test=3:1) (59).